Clinical Trial Update: Effects of Beta-Blocker Therapy and Phosphodiesterase Inhibition on Cardiac Neurohormonal Activation [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating the effects of beta-blocker therapy and phosphodiesterase inhibition on cardiac neurohormonal activation in coronary artery…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: Klinikum Ludwigshafen | Conditions: Coronary Artery Disease | Phase 3 | Status: COMPLETED